Caris Life Sciences Raises $168 Million in Private Capital from Leading Investors to Continue Platform Expansion
IRVING, Texas, April 7, 2025 /PRNewswire/ — Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the company has closed a growth capital funding round of $168 million. With this funding, Caris…